- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-03-0068628

Raxem Bio Tech Private Limited
About Raxem Bio Tech Private Limited
Data last updated:
Raxem Bio Tech Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India. It operates in the medical appliances and instruments segment of the healthcare sector. It was incorporated on 15 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U33100TZ2018PTC029909. Its GSTIN is 33AAICR7202C1ZU (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chakkukumarath Narayanan Subash Chandran and Kurup Nalinakshan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No:11 Peumal Konar Street Edayarpalayam, Coimbatore, Tamil Nadu, India – 641008.
As per the financials filed for FY 2023, the company reported a revenue of ₹6.45 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹15.25 Lakh (net margin 2.4%) and EBITDA of ₹20.66 Lakh (EBITDA margin 3.2%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years.
Raxem Bio Tech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-03-0068628).
Recognitions & Rankings of Raxem Bio Tech
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo:11 Peumal Konar Street Edayarpalayam, Coimbatore, Tamil Nadu, India – 641008
- IndustryHealthcare, Medical Appliances And Instruments, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Raxem Bio Tech Private Limited
The main business activity of Raxem Bio Tech is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Raxem Bio Tech Private Limited FY 2025 filings available
Raxem Bio Tech Private Limited reported revenue of ₹6.45 Cr (up 26% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Raxem Bio Tech Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 32% over three years, including 26% growth in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Raxem Bio Tech Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20.66 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.25 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Raxem Bio Tech Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Raxem Bio Tech are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Raxem Bio Tech Private Limited
Raxem Bio Tech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chakkukumarath Narayanan Subash Chandran Also directs: Vcare Healthcare Private Limited, City Pharrma Private Limited | Director | 15 Jan 2018 | 8 Years 9 Months | Current |
| Kurup Nalinakshan Also directs: Vcare Healthcare Private Limited, City Pharrma Private Limited | Director | 15 Jan 2018 | 8 Years 9 Months | Current |
Peer Comparison of Raxem Bio Tech Private Limited
Raxem Bio Tech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ckris Laboratories Private Limited | ₹6.47 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Navi Mumbai, Maharashtra, India |
| Wasazra Pharmaceuticals Limited | ₹6.46 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | Lucknow, Uttar Pradesh, India |
| Rheo Pharma Private Limited | ₹6.46 Cr (FY 2024) | •••• | •••• | 525.0% | •••• | Hyderabad, Telangana, India |
| Helpline Pharmacy Private Limited | ₹6.45 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | New Delhi, Delhi, India |
| Vira Lifesciences Private Limited | ₹6.45 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Lucknow, Uttar Pradesh, India |
| Raxem Bio Tech Private Limited this company | ₹6.45 Cr (FY 2023) | •••• | •••• | 26.0% | •••• | Coimbatore, Tamil Nadu, India |
| Tejaswi Biotech Private Limited | ₹6.43 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Delhi, India |
| Lifecom Prima (India) Private Limited | ₹6.43 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Roorkee, Uttarakhand, India |
| Kailash Health Solutions Private Limited | ₹6.43 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Delhi, India |
| Karad Veterinary Sales and Service Centre Private Limited | ₹6.43 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Malakapur, Maharashtra, India |
| Achieva Healthcare Private Limited | ₹6.43 Cr (FY 2019) | •••• | •••• | 0.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Raxem Bio Tech by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Raxem Bio Tech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Raxem Bio Tech Private Limited
Raxem Bio Tech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Raxem Bio Tech Private Limited
Employment history and EPFO contributions of people linked to Raxem Bio Tech.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Raxem Bio Tech Private Limited
Raxem Bio Tech Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Chakkukumarath Narayanan Subash Chandran was appointed as Director on 15 Jan 2018.
Credit Ratings, Litigation & Regulatory Alerts for Raxem Bio Tech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Raxem Bio Tech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Raxem Bio Tech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Raxem Bio Tech Private Limited
Raxem Bio Tech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICR7202C1ZU | Tamil Nadu | Active | 25 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Raxem Bio Tech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raxem Bio Tech Private Limited
Raxem Bio Tech is an active private limited company based in Coimbatore, Tamil Nadu, India. The company works in medical appliances and instruments, within the healthcare industry. It was incorporated on 15 January 2018 (8+ years old) and is registered under CIN U33100TZ2018PTC029909.
Raxem Bio Tech reported revenue of ₹6.45 Cr for FY 2023 (up 26% YoY).
Raxem Bio Tech has 2 current directors:
- Chakkukumarath Narayanan Subash Chandran - Director
- Kurup Nalinakshan - Director
Raxem Bio Tech reported a net profit of ₹15.25 Lakh (net margin 2.4%) and EBITDA of ₹20.66 Lakh (EBITDA margin 3.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Raxem Bio Tech is 32% over three years. In the latest year (FY 2023) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Raxem Bio Tech is 33AAICR7202C1ZU, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Raxem Bio Tech is U33100TZ2018PTC029909. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raxem Bio Tech was incorporated on 15 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Raxem Bio Tech by revenue are Ckris Laboratories Private Limited, Wasazra Pharmaceuticals Limited, Rheo Pharma Private Limited, Helpline Pharmacy Private Limited, Vira Lifesciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Chakkukumarath Narayanan Subash Chandran was appointed as Director on 15 Jan 2018. Kurup Nalinakshan was appointed as Director on 15 Jan 2018.
Yes, Raxem Bio Tech is registered as a small enterprise under Udyam registration (number: UDYAM-TN-03-0068628).